FDA does not approve MDMA therapy in a surprising blow to the psychedelic renaissance

The FDA has decided not to approve MDMA therapy for the treatment of post-traumatic stress disorder, dealing an unexpected blow to the growing movement to raise psychedelics from the underground as a new, strangely powerful type of medicine.

Psychoactive drugs like psilocybin, LSD, and MDMA have…